Navigating the New Requirements for USP 800 Drugs.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 161
- Publication type:
- Article
Works matching IS 21641153 AND DT 2016 AND VI 6 AND IP 4
Results: 8
1
2
Lowering the High Cost of USP 800 Compliance.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 160
- Publication type:
- Article
3
Challenges in ALK-Positive NSCLC Management.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 158
- By:
- Publication type:
- Article
4
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.
- Published in:
- 2016
- Publication type:
- Abstract
5
Making an Informed Treatment Choice for Aggressive Non-Hodgkin Lymphoma: The R-CHOP Regimen versus EPOCH-R.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 145
- By:
- Publication type:
- Article
6
Efficacy and Cost Analysis of a Plerixafor Protocol for Peripheral Blood Stem-Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 139
- By:
- Publication type:
- Article
7
Overview of the Current Development Landscape in Chronic Lymphocytic Leukemia, Part 3.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 124
- By:
- Publication type:
- Article
8
New and Emerging Developments in the Management of Chronic Lymphocytic Leukemia: Role of the Pharmacist.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2016, v. 6, n. 4, p. 122
- By:
- Publication type:
- Article